SUBCHRONIC EFFECTS FOLLOWING A SINGLE SARIN EXPOSURE ON BLOOD-BRAIN AND BLOOD-TESTES BARRIER PERMEABILITY, ACETYLCHOLINESTERASE, AND ACETYLCHOLINE RECEPTORS IN THE CENTRAL NERVOUS SYSTEM OF RAT: A DOSE-RESPONSE STUDY

Subchronic neurotoxic effects of sarin (O-isopropyl methylphosphonofluoridate) treatment at various doses in male Sprague Dawley rats were studied. The animals were treated with a single intramuscular (im) injection of 0.01, 0.1, 0.5, or 1 x LD50 (100 microg/kg). The animals were maintained for 90 d...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Toxicology and Environmental Health, Part A Vol. 61; no. 8; pp. 695 - 707
Main Authors: Jones, Katherine H., Dechkovskaia, Anjelika M., Herrick, Elizabeth A., Abdel-Rahman, Ali A., Khan, Wasiuddin A., Abou-Donia, Mohamed B.
Format: Journal Article
Language:English
Published: England Informa UK Ltd 29-12-2000
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Subchronic neurotoxic effects of sarin (O-isopropyl methylphosphonofluoridate) treatment at various doses in male Sprague Dawley rats were studied. The animals were treated with a single intramuscular (im) injection of 0.01, 0.1, 0.5, or 1 x LD50 (100 microg/kg). The animals were maintained for 90 d thereafter. [3H]Hexamethonium iodide was used to monitor the changes in blood-brain barrier (BBB) permeability in cortex, brainstem, midbrain, and cerebellum. Brainstem exhibited a significant decrease (approximately 58% of control) in uptake of [3H]hexamethonium iodide at 1 x LD50 dose. No significant changes were observed in BBB permeability in cortex, midbrain, and cerebellum at any dose. Plasma butyrylcholinesterase (BChE) activity remained unchanged, reflecting recovery of the enzyme activity from the initial inhibition following single exposure of 1 x LD50 sarin. Acetylcholinesterase (AChE) activity in the cortex remained inhibited (approximately 29%), whereas in the brainstem there was an increase (approximately 20%) at 1 x LD50 dose of sarin. The m2-selective muscarinic acetylcholine receptor (m2-mAChR) ligand binding was inhibited significantly at 1 x LD50 in the cortex, whereas brainstem showed significantly increased (approximately 45%) ligand binding at 1 x LD50 dose. Nicotinic acetylcholine receptor (nAChR), on the other hand, showed a biphasic response in ligand binding in the cortex with a decrease (approximately 30%) at 0.01 x LD50 but an increase (approximately 40%) at 1 x LD5O. Brainstem did not show any significant change in nAChR ligand binding. These results suggest that single exposure of sarin could lead to changes that may play an important role in neuropathological abnormalities in the central nervous system.
AbstractList Male Sprague Dawley rats were exposed to a single dose of sarin at concentrations of 0.01, 0.1, 0.5, and 1 LD sub(50) (100 mu g/kg), and subchronic effects were examined after 90 d of treatment. At the highest dose, animals exhibited severe tremors, seizures, and salivation within 5 15 min of treatment, increasing in severity up to 30 min. Brainstem exhibited a significant decrease in permeability at the highest dose, and an increase in barrier permeability was observed in testes at the 0.1 and the highest dose. Sarin exposure at 0.5 or 1 LD sub(50) caused a decrease in the blood brain barrier permeability in brainstem and at 1 LD sub(50) in the cortex. Even though the sarin-inhibited acetylcholinesterase (AChE) activity recovered rapidly, the cortex activity remained inhibited slightly after 90 d, suggesting that there were regional differences in the brain recovery of AChE following inhibition by sarin. After 90 d, there was an increase in ligand-binding densities of m2-selective muscarinic acetylcholine receptor in the brainstem, and there was a decrease in the cortex.
Subchronic neurotoxic effects of sarin (O-isopropyl methylphosphonofluoridate) treatment at various doses in male Sprague Dawley rats were studied. The animals were treated with a single intramuscular (im) injection of 0.01, 0.1, 0.5, or 1 x LD50 (100 microg/kg). The animals were maintained for 90 d thereafter. [3H]Hexamethonium iodide was used to monitor the changes in blood-brain barrier (BBB) permeability in cortex, brainstem, midbrain, and cerebellum. Brainstem exhibited a significant decrease (approximately 58% of control) in uptake of [3H]hexamethonium iodide at 1 x LD50 dose. No significant changes were observed in BBB permeability in cortex, midbrain, and cerebellum at any dose. Plasma butyrylcholinesterase (BChE) activity remained unchanged, reflecting recovery of the enzyme activity from the initial inhibition following single exposure of 1 x LD50 sarin. Acetylcholinesterase (AChE) activity in the cortex remained inhibited (approximately 29%), whereas in the brainstem there was an increase (approximately 20%) at 1 x LD50 dose of sarin. The m2-selective muscarinic acetylcholine receptor (m2-mAChR) ligand binding was inhibited significantly at 1 x LD50 in the cortex, whereas brainstem showed significantly increased (approximately 45%) ligand binding at 1 x LD50 dose. Nicotinic acetylcholine receptor (nAChR), on the other hand, showed a biphasic response in ligand binding in the cortex with a decrease (approximately 30%) at 0.01 x LD50 but an increase (approximately 40%) at 1 x LD5O. Brainstem did not show any significant change in nAChR ligand binding. These results suggest that single exposure of sarin could lead to changes that may play an important role in neuropathological abnormalities in the central nervous system.
Author Khan, Wasiuddin A.
Jones, Katherine H.
Abdel-Rahman, Ali A.
Dechkovskaia, Anjelika M.
Herrick, Elizabeth A.
Abou-Donia, Mohamed B.
Author_xml – sequence: 1
  givenname: Katherine H.
  surname: Jones
  fullname: Jones, Katherine H.
– sequence: 2
  givenname: Anjelika M.
  surname: Dechkovskaia
  fullname: Dechkovskaia, Anjelika M.
– sequence: 3
  givenname: Elizabeth A.
  surname: Herrick
  fullname: Herrick, Elizabeth A.
– sequence: 4
  givenname: Ali A.
  surname: Abdel-Rahman
  fullname: Abdel-Rahman, Ali A.
– sequence: 5
  givenname: Wasiuddin A.
  surname: Khan
  fullname: Khan, Wasiuddin A.
– sequence: 6
  givenname: Mohamed B.
  surname: Abou-Donia
  fullname: Abou-Donia, Mohamed B.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11132698$$D View this record in MEDLINE/PubMed
BookMark eNqFkV2L1DAYhYusuB_6A7yRXHm11SRt01S8STvpTqHbDEmrzlXpV2Ck065tB91_uj9ns86AyCJC4E3yPudw4FxaZ8M4dJb1FsEPCFL4EcKAughC6EEUeIigF9aFWfg2JhiembuHqe07gXtuXc7zdwMiNyCvrHOEkINJQC-sB1WE0VqKLIkAj2Me5QrEIk3F1yS7AQwoM1IOFJNJBvi3jVCF5EBkIEyFWNmhZOafZavTO-fKHBAyKRMuwYbLW87CJE3y7TVgEc-3abQWaZI9cZIpfv1b_NcGSB7xTS6kAsY7X3MQ8SyXLAUZl19EoYDaGvUtEDGQLP9kUq6E4rbkaiMyZcLmxWr72nqpq37u3pzmlVXEPI_WdipukoilduN6_mJrjQnRDa411RoFRLsdJLBBnoY1aX0aUEy7mvhNW7XQwZQSSrGj6w67OCCwcq6s90ffu2n8cejmpdzv5qbr-2roxsNcItfzAuQjA6Ij2EzjPE-dLu-m3b6a7ksEy6c6y2d1Gs27k_mh3nftH8WpPwP4R2A36HHaVz_HqW_Lpbrvx0lP1dDs5ue25fJrMcrP_1U6_072CFMusVw
CitedBy_id crossref_primary_10_3109_01480545_2014_900070
crossref_primary_10_1016_j_expneurol_2006_07_027
crossref_primary_10_1016_S0006_2952_03_00160_6
crossref_primary_10_1080_15376520500194775
crossref_primary_10_1080_10408444_2016_1220916
crossref_primary_10_1016_S0306_4522_02_00176_8
crossref_primary_10_1016_j_taap_2009_07_035
crossref_primary_10_3390_nu15183952
crossref_primary_10_1016_j_bcp_2005_10_051
crossref_primary_10_1016_S0278_6915_02_00079_0
crossref_primary_10_3109_08958378_2012_750406
ContentType Journal Article
Copyright Copyright Taylor & Francis Group, LLC 2000
Copyright_xml – notice: Copyright Taylor & Francis Group, LLC 2000
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7ST
C1K
SOI
DOI 10.1080/00984100050195161
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Environment Abstracts
Environmental Sciences and Pollution Management
Environment Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Environment Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList Environment Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1087-2620
EndPage 707
ExternalDocumentID 10_1080_00984100050195161
11132698
10067791
Genre Original Articles
Research Support, U.S. Gov't, Non-P.H.S
Journal Article
GroupedDBID .7F
.GJ
.QJ
0BK
0R~
29L
30N
36B
3O-
4.4
53G
5GY
5VS
AAAVI
AAENE
AAGME
AAJMT
AALDU
AAMIU
AAPUL
AAQRR
ABBKH
ABCCY
ABFIM
ABHAV
ABJVF
ABLIJ
ABPEM
ABPTK
ABQHQ
ABTAI
ABXUL
ACDHJ
ACGEJ
ACGFS
ACGOD
ACIWK
ACPRK
ACTIO
ACZPZ
ADCVX
ADGTB
ADOPC
ADXPE
AEGYZ
AEISY
AEOZL
AFKVX
AFOLD
AFRAH
AFWLO
AGDLA
AGMYJ
AHDLD
AIJEM
AIRXU
AJWEG
AKBVH
AKOOK
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AQRUH
AURDB
AVBZW
AWYRJ
BFWEY
BLEHA
CAG
CCCUG
CE4
COF
CS3
CWRZV
DGEBU
DKSSO
EBS
ECGQY
EJD
E~A
E~B
F5P
FUNRP
FVPDL
GTTXZ
HZ~
H~P
IPNFZ
J.P
KYCEM
M4Z
NA5
NX0
O9-
P2P
PCLFJ
PQEST
PQQKQ
RIG
RNANH
ROSJB
RTWRZ
S-T
SNACF
TEI
TFL
TFT
TFW
TQWBC
TTHFI
TWF
UT5
UU3
V1K
YHZ
ZGI
ZGOLN
ZXP
~S~
ABPAQ
ABXYU
CGR
CUY
CVF
ECM
EIF
H13
NPM
TBQAZ
TUROJ
AAYXX
CITATION
7ST
C1K
SOI
ID FETCH-LOGICAL-c457t-ff266fc2bf8ff196f4e060c15f0b6d789828eb67cdad0328868823fbe242960a3
IEDL.DBID TFW
ISSN 1528-7394
IngestDate Fri Oct 25 08:21:57 EDT 2024
Fri Aug 23 03:56:19 EDT 2024
Tue Oct 15 23:22:17 EDT 2024
Tue Jun 13 19:49:18 EDT 2023
Mon May 13 12:10:38 EDT 2019
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c457t-ff266fc2bf8ff196f4e060c15f0b6d789828eb67cdad0328868823fbe242960a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 11132698
PQID 14559171
PQPubID 23462
PageCount 13
ParticipantIDs proquest_miscellaneous_14559171
informaworld_taylorfrancis_310_1080_00984100050195161
pubmed_primary_11132698
crossref_primary_10_1080_00984100050195161
PublicationCentury 2000
PublicationDate 2000-Dec-29
PublicationDateYYYYMMDD 2000-12-29
PublicationDate_xml – month: 12
  year: 2000
  text: 2000-Dec-29
  day: 29
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of Toxicology and Environmental Health, Part A
PublicationTitleAlternate J Toxicol Environ Health A
PublicationYear 2000
Publisher Informa UK Ltd
Publisher_xml – name: Informa UK Ltd
SSID ssj0001496
ssj0001687
Score 1.7239804
Snippet Subchronic neurotoxic effects of sarin (O-isopropyl methylphosphonofluoridate) treatment at various doses in male Sprague Dawley rats were studied. The animals...
Male Sprague Dawley rats were exposed to a single dose of sarin at concentrations of 0.01, 0.1, 0.5, and 1 LD sub(50) (100 mu g/kg), and subchronic effects...
SourceID proquest
crossref
pubmed
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 695
SubjectTerms Acetylcholinesterase - analysis
Acetylcholinesterase - drug effects
Animals
Binding Sites
Blood-Brain Barrier - drug effects
Blood-Brain Barrier - physiology
Blood-Testis Barrier - drug effects
Blood-Testis Barrier - physiology
Central Nervous System - metabolism
Chemical Warfare Agents - pharmacokinetics
Chemical Warfare Agents - toxicity
Dose-Response Relationship, Drug
Lethal Dose 50
Ligands
Male
Permeability
Persian Gulf Syndrome - etiology
Rats
Rats, Sprague-Dawley
Receptors, Cholinergic - analysis
Receptors, Cholinergic - drug effects
Sarin - pharmacokinetics
Sarin - toxicity
Title SUBCHRONIC EFFECTS FOLLOWING A SINGLE SARIN EXPOSURE ON BLOOD-BRAIN AND BLOOD-TESTES BARRIER PERMEABILITY, ACETYLCHOLINESTERASE, AND ACETYLCHOLINE RECEPTORS IN THE CENTRAL NERVOUS SYSTEM OF RAT: A DOSE-RESPONSE STUDY
URI https://www.tandfonline.com/doi/abs/10.1080/00984100050195161
https://www.ncbi.nlm.nih.gov/pubmed/11132698
https://search.proquest.com/docview/14559171
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jj5swFLbaOVWquky3TLd3qOZQBZUdU6kHQpwGicHIJp3JCUHAx0zVJNLMP-3P6TMkk6bLHFoJCRm8IT7b3_PyPULeVaGpPEtRo7Xt0HBdszJqx3UNy1nUtEEU2Z3_lKkMsgs6Zlom59PuLIzeVqltaNULRXR9tW7cVb3a7Yj7oDUwXauTLrGQIHTGj9bbRjQXk_Obfhi5v78P-J2vPBytqBE4obtb4PxTdgdD1IGA6d9paDccTR7-54c8Ig-2PBSiHjiPyZ12eUxO817I-noIxf5c1moIp5DvJa6vj8n9frYP-kNMT8h3ORvFU8GzJAZkviwuJEx4mvLzJPsMEUi8pQxkJJIM2EXO5Uww4BmMUs7HxkhE-DzKxttwwSReMIqESJiAnIkzFo2SNCnmQ4hiVsxTvQKmHYYgG48kG3aJD96AYDHLCy4kYN7FlEHMMu0gGjImvvCZBDnH1GfAJyCi4iPWcswlMxCROc8kVha58vwpmU1YEU-Nrc8IY-F6wdpQChmHWti1okph76Lc1vTNheUps_abgIZoYba1HyyaqtFSgtRHE8NRdYtUBY25ynlGjpaXy_YFAVXZWrk88Cqzcj0k0oHveyp0VOPX1KN0QN7vYFJ-7aVBSutGcfWXPzsg5s9AKtfdfIzqnaf8Hr1cX60HxLsliXNLUW93IC2xr9ALQNWyvdysSt1I0DzHGM977O7rbVnI40N68o9lviT3Oo0Cyzbs8BU5Wn_btK_J3VWzedM1yh9coSA1
link.rule.ids 315,782,786,1455,1509,27935,27936,58024,59737,60526
linkProvider Taylor & Francis
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jj9MwFLZgOICEWIatbPMOaA6oEdkXDkhp6tKINI7slJmeomw-dhBtJeaf8nN4TtopZZkDSJEiO94iPz9_z8v3CHlTBrp0DOlrrWkGmm3rpVZZtq0ZVl35DUqR2flPmQovPffHVNHkfNjdhVHHKpUNLXuiiE5Xq8GtFqN3R-LeKRJM2-i4SwxECMr6uYXA2FLGVz45u9LEiP7dfcDtvOXhfOVrnhXYuy3OP5V3MEkdUJj-HYh2E9Lk_v_-ygNybwtFIexl5yG50S6PyWnWc1lfDiHfX81aDeEUsj3L9eUxudsv-EF_j-kR-S7mo2jKWRpHgOCXRrmACUsSdhanHyEEga-Eggh5nAI9z5iYcwoshVHC2Fgb8RDjw3S8DedU4AOjkPOYcsgon9FwFCdxvhhCGNF8kahNMOUzBAF5KOiwy3zwBTiNaJYzLgDLzqcUIpoqH9GQUv6ZzQWIBeaeAZsAD_P32MoxE1RDocxYKrCxCJcXj8l8QvNoqm3dRmi17XhrTUoEHbI2K-lLiQpG2q3u6rXhSL1yG88P0MhsK9erm7JRbIK-i1aGJasW0Qrac6X1hBwtL5btMwKyNBV5ueeUemk7iKU913VkYMnGrXzH9wfk7U5Oii89O0hhXJGu_tKzA6L_LEnFuluSkb3_lN-TF-tv6wFxrsliXVPVyU5KC1QXag-oXLYXm1WheOnRQscUT3vh3bfbMBDKB_7zf6zzhNye5rOkwP799ILc6SgLDFMzg5fkaP11074iN1fN5nU3Qn8Ax6kkXA
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Za9tAEF7aFEqh9Egv98o8lDwUi-o-Cn2Q5VUtqmjFrpzET0KytI9OqG1o_ml_TmclO6575KEFgZC0l9jZmW_2-IaQd1WgS8eQvtaaZqDZtl5ptWXbmmHNa79BKTK7-CkT4WXn_pgqmpxP27Mwalul8qFlTxTR6Wo1uC8bud0R90FxYNpGR11iIEBQzs8dx0djg-JcxGfXihjBv7t7cLtgeWiufM2zAnu7wvmn8vZs1B6D6d9xaGeP4of_-SePyIMNEIWwl5zH5Fa7OCTHec9kfTWEYncwazmEY8h3HNdXh-R-P90H_SmmJ-S7mI6iCWdZEgFCXxoVAmKWpuwsyT5DCAJvKQUR8iQDep4zMeUUWAajlLGxNuIhvg-z8ea5oAIvGIWcJ5RDTvkJDUdJmhSzIYQRLWapWgJTEUMQjoeCDrvMe1-A04jmBeMCsOxiQiGimYoQDRnlp2wqQMww9wmwGHhYfMRWjpmgGopkzjKBjUWwPHtKpjEtoom2CRqhzW3HW2lSIuSQc7OWvpSoXqTd6q4-Nxyp127j-QG6mG3tevOmahSXoO-ij2HJukWsgt5cZT0jB4uLRfuCgKxMRV3uOZVe2Q4iac91HRlYsnFr3_H9AXm_FZPysucGKY1rytVfenZA9J8FqVx1EzKyj57ye_Jy9W01IM4NWawbqjraCmmJykKtAFWL9mK9LBUrPfrnmOJ5L7u7dhsGAvnAf_mPdR6Ru_k4LrF7v7wi9zq-AsPUzOA1OVh9XbdvyO1ls37bjc8f0pojAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SUBCHRONIC+EFFECTS+FOLLOWING+A+SINGLE+SARIN+EXPOSURE+ON+BLOOD-BRAIN+AND+BLOOD-TESTES+BARRIER+PERMEABILITY%2C+ACETYLCHOLINESTERASE%2C+AND+ACETYLCHOLINE+RECEPTORS+IN+THE+CENTRAL+NERVOUS+SYSTEM+OF+RAT%3A+A+DOSE-RESPONSE+STUDY&rft.jtitle=Journal+of+Toxicology+and+Environmental+Health%2C+Part+A&rft.au=Jones%2C+Katherine+H.&rft.au=Dechkovskaia%2C+Anjelika+M.&rft.au=Herrick%2C+Elizabeth+A.&rft.au=Abdel-Rahman%2C+Ali+A.&rft.date=2000-12-29&rft.pub=Informa+UK+Ltd&rft.issn=1528-7394&rft.eissn=1087-2620&rft.volume=61&rft.issue=8&rft.spage=695&rft.epage=707&rft_id=info:doi/10.1080%2F00984100050195161&rft.externalDocID=10067791
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-7394&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-7394&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-7394&client=summon